VacciMonitor
|
Drug Discovery |
26 |
0.4 |
132 |
Q4 |
Journal of Pharmaceutical Negative Results
|
Drug Discovery |
38 |
0.9 |
124 |
Q4 |
Molecular Therapy - Nucleic Acids
|
Drug Discovery |
10221 |
9.8 |
11 |
Q1 |
Emerging Microbes and Infections
|
Drug Discovery |
7504 |
11.6 |
8 |
Q1 |
Vaccines
|
Drug Discovery |
2951 |
2.7 |
94 |
Q3 |
Journal of Applied Research on Medicinal and Aromatic Plants
|
Drug Discovery |
856 |
4.8 |
62 |
Q2 |
Natural Products Journal
|
Drug Discovery |
158 |
0.9 |
121 |
Q4 |
Journal of Pharmacy and Pharmacognosy Research
|
Drug Discovery |
215 |
1.3 |
115 |
Q4 |
Cell Chemical Biology
|
Drug Discovery |
7387 |
12.9 |
7 |
Q1 |
Drug Research
|
Drug Discovery |
1337 |
3.7 |
80 |
Q3 |
Current Pharmacology Reports
|
Drug Discovery |
532 |
3.4 |
88 |
Q3 |
Journal of HerbMed Pharmacology
|
Drug Discovery |
387 |
2.3 |
104 |
Q3 |
Current Opinion in Systems Biology
|
Drug Discovery |
1622 |
5.8 |
39 |
Q2 |
Expert Review of Precision Medicine and Drug Development
|
Drug Discovery |
241 |
1.9 |
109 |
Q3 |
Latin American Journal of Pharmacy
|
Drug Discovery |
733 |
0.5 |
127 |
Q4 |
npj Systems Biology and Applications
|
Drug Discovery |
1075 |
7.1 |
26 |
Q1 |
Journal of Biologically Active Products from Nature
|
Drug Discovery |
192 |
1.2 |
118 |
Q4 |
Tropical Journal of Natural Product Research
|
Drug Discovery |
118 |
0.3 |
136 |
Q4 |
Frontiers in Clinical Drug Research - Anti Infectives
|
Drug Discovery |
7 |
0.6 |
126 |
Q4 |
RSC Medicinal Chemistry
|
Drug Discovery |
4067 |
5.7 |
41 |
Q2 |
Frontiers in Clinical Drug Research - Anti Allergy Agents
|
Drug Discovery |
0 |
0.0 |
143 |
Q4 |
Cancer Drug Discovery and Development
|
Drug Discovery |
84 |
0.8 |
125 |
Q4 |
Drug Development and Registration
|
Drug Discovery |
10 |
0.1 |
142 |
Q4 |
Frontiers in Anti-infective Drug Discovery
|
Drug Discovery |
0 |
0.0 |
143 |
Q4 |
Molecular and Integrative Toxicology
|
Drug Discovery |
108 |
1.2 |
120 |
Q4 |